CARSON CITY, Nev., June 30, 2006 (PRIMEZONE) -- Avitech Lifesciences Inc. (Other OTC:AVLF) announced that it has directed focus on the production and manufacturing of a natural product formulated to aid in the battle against the potential pandemic of the Avian Flu.
The decision was made after learning of reports that the World Health Organization (WHO) has developed pandemic contingency and containment plans with use of anti-viral drugs at their foundation. The World Health Organization recognized that these strategic tools may have severe limitations. These range from lack of effective vaccines in early stages, shortage of availability, to the risk of multiple viral strains emerging.
The alarming information has prompted Avitech Lifesciences Inc. to concentrate on production of our homeopathic product that is directed specifically at the H5N1 virus strain. It has been noted that in all probability the virus will possess the variability to develop new strains. Although still unclear, it is likely that this product may also be effective for mutations of the H5N1 strain.
Avitech currently is assessing supply availability of the active ingredient in order to meet prospective contingencies. The Company will then take immediate measures to procure the essential ingredient in hope that sufficient time is allotted to manufacture and make available an adequate supply of the product should a pandemic occur.
Please visit our website at www.avitechls.com for further information and developments.
About Avitech Lifesciences Inc.
Avitech Lifesciences Inc. is a firm focused on health and life sciences industry. Avitech helps entrepreneurs accelerate their business development by investing early in the Company's development and taking an active role in its day to day operations by acting as collaborative partners with the companies we bring on board. Although Avitech Lifesciences Inc. primary mandate is health and life sciences sector the Company's mandate will allow it to look at all investments to increase shareholder value.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.